Want to see IN:PRIVISCL full AI Analyst Report?
Top Page
Privi Speciality Chemicals Limited
(PRIVISCL)
Select Model
Select Model
Rating:59Neutral
Price Target:
₹3,640.00
▲(31.01% Upside)
Action:Reiterated
Date:08/17/26
The score is supported by improving fundamentals—better earnings, FY2026 deleveraging, and a strong free-cash-flow rebound—but is held back by weak current technical momentum and a relatively expensive valuation (high P/E with minimal dividend yield).
Positive Factors
Steady Revenue Growth
Continued revenue growth indicates expanding demand for Privi’s aroma chemicals and intermediates. Sustained sales progression can support better plant utilization and operating leverage, although the pace and quality of growth remain important to monitor.
Negative Factors
Margin Volatility
Uneven margins suggest profitability remains sensitive to raw-material costs, selling prices, product mix, or chemical-cycle conditions. This can make earnings less predictable and may limit the durability of the recent profit improvement if input-cost pressure returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Steady Revenue Growth
Continued revenue growth indicates expanding demand for Privi’s aroma chemicals and intermediates. Sustained sales progression can support better plant utilization and operating leverage, although the pace and quality of growth remain important to monitor.
Read all positive factors
Privi Speciality Chemicals Limited (PRIVISCL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹131.56B
Dividend Yield0.3%
Average Volume (3M)3.69K
Price to Earnings (P/E)38.0
Beta (1Y)0.74
Revenue Growth21.63%
EPS Growth60.79%
CountryIN
Employees711
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)89.56
Shares Outstanding39,062,702
10 Day Avg. Volume2,914
30 Day Avg. Volume3,692
Financial Highlights & Ratios
PEG Ratio0.46
Price to Book (P/B)8.01
Price to Sales (P/S)4.42
P/FCF Ratio75.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹3,900.00Price Target Upside40.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)117.87
Revenue Forecast (FY)₹30.73B
Privi Speciality Chemicals Limited Business Overview & Revenue Model
Company Description
Privi Speciality Chemicals Limited is a global manufacturer, supplier, and exporter of a diverse range of aroma and fragrance compounds, with operations extending internationally from its base in India. Its extensive product portfolio encompasses ...
How the Company Makes Money
Privi Speciality Chemicals Limited makes money by manufacturing and selling specialty aroma/fragrance chemicals and related chemical intermediates to customers that formulate and use these inputs in finished products. Its revenue model is largely ...
Privi Speciality Chemicals Limited Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
71
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.71B | 25.64B | 20.92B | 17.52B | 16.05B | 14.02B |
| Gross Profit | 9.95B | 8.14B | 9.03B | 6.96B | 5.98B | 5.32B |
| EBITDA | 6.92B | 6.65B | 4.74B | 3.51B | 2.07B | 2.32B |
| Net Income | 3.50B | 3.28B | 1.87B | 949.07M | 222.15M | 973.80M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 31.70B | 27.91B | 23.43B | 23.91B | 21.76B |
| Cash, Cash Equivalents and Short-Term Investments | 976.84M | 1.23B | 577.31M | 635.46M | 271.77M | 445.19M |
| Total Debt | 0.00 | 10.21B | 11.43B | 10.08B | 10.79B | 9.30B |
| Total Liabilities | -14.41B | 17.29B | 16.73B | 14.01B | 15.56B | 13.56B |
| Stockholders Equity | 14.41B | 14.12B | 11.03B | 9.24B | 8.29B | 8.12B |
Cash Flow | ||||||
| Free Cash Flow | 800.31M | 1.51B | -180.27M | 2.04B | -909.33M | -3.04B |
| Operating Cash Flow | 2.35B | 4.71B | 2.81B | 3.54B | 487.59M | 47.36M |
| Investing Cash Flow | -1.33B | -3.34B | -2.94B | -1.80B | -1.33B | -3.20B |
| Financing Cash Flow | -1.35B | -1.42B | 386.33M | -1.71B | 723.05M | 3.33B |
Privi Speciality Chemicals Limited Technical Analysis
Negative
2778.50
Price Trends
3563.99
Negative
3430.32
Negative
3181.08
Positive
Market Momentum
-52.75
Positive
37.58
Neutral
52.12
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:PRIVISCL, the sentiment is Negative. The current price of 2778.5 is below the 20-day moving average (MA) of 3450.37, below the 50-day MA of 3563.99, and below the 200-day MA of 3181.08, indicating a neutral trend. The MACD of -52.75 indicates Positive momentum. The RSI at 37.58 is Neutral, neither overbought nor oversold. The STOCH value of 52.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:PRIVISCL.
Privi Speciality Chemicals Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹135.83B | 30.26 | ― | 0.63% | 5.09% | 5.44% | |
70 Neutral | ₹157.83B | 36.51 | ― | 0.21% | 7.26% | 5.73% | |
67 Neutral | ₹215.88B | 91.45 | ― | ― | 33.79% | 34.24% | |
59 Neutral | ₹131.56B | 37.97 | ― | 0.28% | 21.63% | 60.79% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | ₹141.02B | 80.23 | ― | 0.12% | 51.77% | 36.94% | |
53 Neutral | ₹47.82B | 38.01 | ― | 0.17% | 5.47% | 24.88% |
* General Sector Average
IN:PRIVISCL
Privi Speciality Chemicals Limited
3,377.50
1,092.52
47.81%
IN:AETHER
Aether Industries Ltd.
1,618.80
878.45
118.65%
IN:ANURAS
Anupam Rasayan India Ltd.
1,232.95
148.50
13.69%
IN:FINEORG
Fine Organic Industries Ltd.
5,123.15
291.46
6.03%
IN:LXCHEM
Laxmi Organic Industries Ltd.
172.05
-40.59
-19.09%
IN:VINATIORGA
Vinati Organics Limited
1,298.80
-398.21
-23.47%
Privi Speciality Chemicals Limited Corporate Events
Privi Speciality Chemicals secures strong shareholder approval at 41st AGM
Aug 10, 2026
Privi Speciality Chemicals Limited reported the voting results of its 41st Annual General Meeting held on August 7, 2026, confirming that all resolutions, including the adoption of audited standalone and consolidated financial statements for the y...
Privi Speciality Chemicals Sets August 7 Virtual AGM, Proposes 100% Final Dividend
Jul 11, 2026
Privi Speciality Chemicals Limited has scheduled its 41st Annual General Meeting for August 7, 2026, to be held via video conferencing, and has circulated the AGM notice and the 2025-26 annual report electronically to shareholders. The company has...
Privi Speciality Chemicals Sets Virtual AGM and Final Dividend for 2026
Jul 8, 2026
Privi Speciality Chemicals Limited has announced that its 41st Annual General Meeting will be held on August 7, 2026, via video conferencing and other audio-visual means in line with the Companies Act and SEBI listing regulations. Shareholders par...
Privi Speciality Chemicals Promoter Reports No Encumbrance on Shares for FY 2026
May 29, 2026
Privi Speciality Chemicals Limited has informed the stock exchanges that its promoter and promoter group have submitted the annual disclosure required under Regulation 31(4) of SEBI’s Substantial Acquisition of Shares and Takeovers Regulatio...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.